Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
meeting entities : Regenxbio inc. save search
REGENXBIO Announces Presentation at the Hawaiian Eye and Retina 2024 Meeting
Published: 2024-01-10 (Crawled : 12:00) - prnewswire.com
SRPT | $117.05 -0.71% 150K
|
Health Technology
|
| O: 1.79%
H: 0.0%
C: -2.23%
RGNX | News | $16.67 -2.11% 150K
|
Health Technology
|
| O: -0.48%
H: 2.74%
C: 1.85%
presentation retina meeting eye
REGENXBIO Announces Presentations at the American Academy of Ophthalmology 2023 Annual Meeting
Published: 2023-10-30 (Crawled : 11:00) - prnewswire.com
RGNX | News | $16.67 -2.11% 150K
|
Health Technology
|
| O: 1.32%
H: 1.99%
C: -1.37%
meeting
REGENXBIO Announces Upcoming Presentations at the American Society of Retina Specialists Annual Scientific Meeting
Published: 2023-07-24 (Crawled : 20:00) - prnewswire.com
RGNX | News | $16.67 -2.11% 150K
|
Health Technology
|
| O: -0.55%
H: 1.11%
C: -1.23%
retina meeting
REGENXBIO Announces Presentations at the American Society of Gene & Cell Therapy 26th Annual Meeting
Published: 2023-05-02 (Crawled : 21:00) - prnewswire.com
RGNX | News | $16.67 -2.11% 150K
|
Health Technology
|
| O: 0.05%
H: 5.85%
C: 3.74%
cell meeting therapy
Positive Data Presentations at AAO Annual Meeting Demonstrate Utility and Versatility of Clearside Biomedical’s Proprietary Suprachoroidal Space Platform
Published: 2022-10-04 (Crawled : 13:00) - biospace.com/
RGNX | News | $16.67 -2.11% 150K
|
Health Technology
|
| O: 0.66%
H: 8.18%
C: -7.11%
CLSD | $1.37 8.73% 300K
|
Health Technology
|
| O: 1.67%
H: 15.57%
C: 12.3%
space meeting positive platform
REGENXBIO Announces Upcoming Presentations During the American Academy of Ophthalmology 2022 Annual Meeting
Published: 2022-09-26 (Crawled : 12:00) - biospace.com/
RGNX | News | $16.67 -2.11% 150K
|
Health Technology
|
| O: -0.35%
H: 2.59%
C: -2.15%
meeting
REGENXBIO Announces Presentations at the American Society of Gene & Cell Therapy (ASGCT) 25th Annual Meeting
Published: 2022-05-03 (Crawled : 12:00) - biospace.com/
RGNX | News | $16.67 -2.11% 150K
|
Health Technology
|
| O: 1.36%
H: 1.48%
C: -0.49%
therapy
Clearside Biomedical Features FDA-Approved XIPERE™ in Multiple Presentations at the American Academy of Ophthalmology 2021 and American Uveitis Society Meetings
Published: 2021-11-16 (Crawled : 12:30) - globenewswire.com
BHC | $8.56 -1.16% 1.1M
|
Health Technology
|
| O: 0.52%
H: 0.26%
C: -1.04%
RGNX | News | $16.67 -2.11% 150K
|
Health Technology
|
| O: -17.59%
H: 2.67%
C: 1.05%
CLSD | $1.37 8.73% 300K
|
Health Technology
|
| O: -2.56%
H: 0.0%
C: 0.0%
presentation fda xipere fda approval
REGENXBIO Announces RGX-314 Data Presentation at the American Academy of Ophthalmology 2021 Annual Meeting
Published: 2021-11-05 (Crawled : 12:00) - biospace.com/
RGNX | News | $16.67 -2.11% 150K
|
Health Technology
|
| O: 2.85%
H: 0.0%
C: 0.0%
CLSD | $1.37 8.73% 300K
|
Health Technology
|
| O: -1.3%
H: 0.38%
C: -1.13%
presentation
REGENXBIO Presents Positive Initial Data from Phase II ALTITUDE™ Trial of RGX-314 for the Treatment of Diabetic Retinopathy Using Suprachoroidal Delivery at American Society of Retina Specialists Annual Meeting
Published: 2021-10-09 (Crawled : 16:20) - prnewswire.com
CLSD | $1.37 8.73% 300K
|
Health Technology
| Email alert
Add to watchlist
RGNX | News | $16.67 -2.11% 150K
|
Health Technology
| Email alert
Add to watchlist
treatment positive retina liver trial diabetic diabetes
REGENXBIO Presents Positive Initial Data from Phase II AAVIATE® Trial of RGX-314 for the Treatment of Wet AMD Using Suprachoroidal Delivery and Provides Trial Update at Retina Society 54th Annual Scientific Meeting
Published: 2021-10-01 (Crawled : 00:20) - biospace.com/
RGNX | News | $16.67 -2.11% 150K
|
Health Technology
|
| O: 0.5%
H: 0.0%
C: 0.0%
CLSD | $1.37 8.73% 300K
|
Health Technology
|
| O: -1.5%
H: 0.0%
C: 0.0%
treatment positive retina liver trial
REGENXBIO Announces RGX-314 Data Presentations at American Society of Retina Specialists Annual Meeting
Published: 2021-10-01 (Crawled : 12:00) - biospace.com/
RGNX | News | $16.67 -2.11% 150K
|
Health Technology
|
| O: 0.5%
H: 0.0%
C: 0.0%
CLSD | $1.37 8.73% 300K
|
Health Technology
|
| O: -1.5%
H: 0.0%
C: 0.0%
presentation retina
REGENXBIO Announces RGX-314 Data Presentations at Retina Society 54th Annual Scientific Meeting and KOL Conference Call
Published: 2021-09-27 (Crawled : 12:00) - biospace.com/
RGNX | News | $16.67 -2.11% 150K
|
Health Technology
|
| O: -2.59%
H: 3.84%
C: 3.41%
CLSD | $1.37 8.73% 300K
|
Health Technology
|
| O: 2.08%
H: 1.45%
C: -6.98%
presentation retina conference
REGENXBIO Presents Additional Positive Interim Data from Phase I/II Trial of RGX-121 for the Treatment of MPS II (Hunter Syndrome) at American Society of Gene and Cell Therapy's 24th Annual Meeting
Published: 2021-05-14 (Crawled : 15:15) - biospace.com/
RGNX | News | $16.67 -2.11% 150K
|
Health Technology
|
| O: 1.47%
H: 2.68%
C: 0.92%
treatment positive therapy trial syndros mps-ih
REGENXBIO Announces Presentations at the American Society of Gene and Cell Therapy's 24th Annual Meeting
Published: 2021-04-27 (Crawled : 21:00) - prnewswire.com
RGNX | News | $16.67 -2.11% 150K
|
Health Technology
|
| O: -0.69%
H: 4.61%
C: 3.26%
presentation therapy
Gainers vs Losers
| 73% | 27% |
Top 10 Gainers
AGBA | $1.05 162.5% 100M
|
Finance
ISPC | $0.4621 116.95% 15M
|
Professional, Scientific, and T...
INVO | $1.515 99.34% 4.3M
|
Health Technology
BPTH | $5.62 73.46% 75M
|
Health Technology
TIRX | $0.8231 69.78% 54M
|
SINT | $0.0519 39.14% 350M
|
Health Technology
XPON | $2.63 36.27% 8.4M
|
VTNR S | $1.26 28.68% 9.1M
|
Industrial Services
SWVL | $9.64 27.35% 200K
|
n/a
DFLI A | $0.7726 25.52% 4.3M
|
Your saved searches
Save your searches and get alerts when important news are released.